Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional, Prospective Study of Safety and Efficiency of the Drug Reamberin® in the Intensive Care of Patients With Acute Ethanol Intoxication: Hospital Practice

NCT05715723 is registered in ClinicalTrials.gov with POLYSAN Scientific & Technological Pharmaceutical Company as lead sponsor.

NCT NCT05715723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05715723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional, Prospective Study of Safety and Efficiency of the Drug Reamberin® in the Intensive Care of Patients With Acute Ethanol Intoxication: Hospital Practice
Lead sponsor
POLYSAN Scientific & Technological Pharmaceutical Company
Phase
Observational
Overall status
Completed
Start date
September 15, 2022
Completion date
February 28, 2025
Enrollment
296 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

ethanol intoxication